Improving Outcomes in HPV- and HIV-Related Cervical Cancer

Posted on , updated on by Director

Scientific evidence has shown links among HIV, human papillomavirus (HPV), and cervical cancer.¹ Subsequently, UNAIDS and the World Health Organization have called for leveraging the synergies between these conditions to improve patient outcomes by developing integrated approaches that address HIV, child and adolescent health, sexual and reproductive health and rights, gender equality, and cancer and primary healthcare services to address the interrelated factors that increase the risk for each of these conditions.¹ The hope is that widespread use of such strategies can help prevent unnecessary deaths from cervical cancer and bring an end to the AIDS epidemic by 2030.

References

HPV, HIV, and cervical cancer: leveraging synergies to save women’s lives. UNAIDS. Published 2016. Accessed January 11, 2018.
Key statistics for cervical cancer. American Cancer Society. Accessed January 11, 2018.
Cervical cancer rates by state. Centers for Disease Control and Prevention. Accessed January 11, 2018.
HIV infection and cancer risk. National Cancer Institute. Reviewed September 14, 2017. Accessed January 11, 2018.
Frumovitz F. Invasive cervical cancer: epidemiology, risk factors, clinical manifestations, and diagnosis. UptoDate. Reviewed December 2017. Accessed January 11, 2018.
Draft recommendation statement: cervical cancer screening. US Preventive Services Task Force. Issued October 2017. Accessed January 11, 2018.
6 reasons to get HPV vaccine for your child. Centers for Disease Control and Prevention. Updated August 24, 2017. Accessed January 11, 2018.
Human papillomavirus (HPV) vaccines. National Cancer Institute. Reviewed November 2, 2016. Accessed January 11, 2018.
Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: human papillomavirus disease. US Department of Health and Human Services. Reviewed July 25, 2017. Accessed January 11, 2018.
Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep. 2017;21:101-108.
Levin MJ, Moscicki AB, Song LY, et al; IMPAACT P1047 Protocol Team. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010;55:197-204.
Kahn JA, Xu J, Kapogiannis BG, et al. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013;57:735-744.
Kojic EM, Rana AI, Cu-Uvin S. Human papillomavirus vaccination in HIV-infected women: need for increased coverage. Expert Rev Vaccines. 2016;15:105-117.
Palefsky JM, Holly EA. Chapter 6: Immunosuppression and co-infection with HIV. JNCI Monographs. 2003;31:41-46.
Simonds HM, Wright JD, du Toit N, Neugut AI, Jacobson JS. Completion of and early response to chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa: a retrospective cohort study. Cancer. 2012;118:2971-2979.
Cervical Cancer. Version 1.2018. NCCN Guidelines. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed January 15, 2017.
Ntekim A, Campbell O, Rothenbacher D. Optimal management of cervical cancer in HIV-positive patients: a systematic review. Cancer Medicine. 2015;4:1381-1393.
Does multidisciplinary care improve health outcomes among people living with HIV and/or HCV? A review of the evidence. CATIE. Accessed January 15, 2018.
Grover S, Chiyapo SP, Puri P, et al. Multidisciplinary gynecologic oncology clinic in botswana: a model for multidisciplinary oncology care in low- and middle-income settings. J Glob Oncol. 2017;3:666-670.
ClinicalTrials.gov. Modulated electro-hyperthermia plus chemo-radiation for locally advanced cervical cancer patients in South Africa (mEHT). NCT03332069. Accessed January 15, 2017.

CDC

Transcript: Mpox Briefing
Transcript for Mpox Telebriefing that took place on May 18, 2023.
Update on Rapid Assessment of SARS-CoV-2 Transmission at 2023 EIS Conference
On Thursday, April 27, several in-person attendees at the annual EIS conference notified conference organizers that they had tested positive for SARS-CoV-2, the virus that causes COVID-19.
HIV Declines Among Young People and Drives Overall Decrease in New HIV Infections
The Centers for Disease Control and Prevention (CDC) launched a new Notice of Funding Opportunity (NOFO) through the Center for Forecasting and Outbreak Analytics (CFA) to establish an outbreak response network for disease forecasting to support decision makers during public health emergencies.
New Funding Opportunity to Strengthen Outbreak Response through Data, Forecasting, and Analytics
The Centers for Disease Control and Prevention (CDC) launched a new Notice of Funding Opportunity (NOFO) through the Center for Forecasting and Outbreak Analytics (CFA) to establish an outbreak response network for disease forecasting to support decision makers during public health emergencies.
Transcript: PHE Briefing
Transcript for the COVID-19 Public Health Emergency Announcement
Walensky Announces Departure from CDC
CDC Director Dr. Rochelle Walensky announced today her intent to depart the agency at the end of June. Walensky has led CDC through a transition to greater normalcy across the country, after two years of COVID-19 related closures and waves of dangerous, new virus variants.
CDC’s Disease Detectives Give First-Hand Accounts from the Front Lines of Public Health
The U.S. Centers for Disease Control and Prevention (CDC) will hold its annual Epidemic Intelligence Service (EIS) Conference April 24–27, 2023 in Atlanta. The event will feature 97 presentations on recent groundbreaking investigations and innovative analyses conducted by EIS officers—better known as CDC’s disease detectives.
CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine
Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses.
NIOSH Launches the National Firefighter Registry for Cancer to Understand and Reduce Cancer in the Fire Service
The Centers for Disease Control and Prevention (CDC), through its National Institute for Occupational Safety and Health (NIOSH), are pleased to launch the National Firefighter Registry for Cancer online enrollment system for firefighters across the nation.
U.S. STI Epidemic Showed No Signs of Slowing in 2021 – Cases Continued to Escalate
Reported cases of the sexually transmitted infections (STIs) chlamydia, gonorrhea, and syphilis all increased between 2020 and 2021 – reaching a total of more than 2.5 million reported cases – according to CDC’s final surveillance data.
New Funding Announced to Evaluate Exposure to Environmental Hazards
The ATSDR Partnership to Promote Local Efforts to Reduce Environmental Exposure (APPLETREE) cooperative agreement program will award $13.95 million to fund 30 state health departments to evaluate past and present exposure to environmental hazards and to prevent future exposures.
Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose
The expanded availability of opioid use disorder-related telehealth services and medications during the COVID-19 pandemic was associated with a lowered likelihood of fatal drug overdose among Medicare beneficiaries, according to a new study.
Autism Prevalence Higher, According to Data from 11 ADDM Communities
One in 36 (2.8%) 8-year-old children have been identified with autism spectrum disorder (ASD), according to an analysis published today in CDC’s Morbidity and Mortality Weekly Report (MMWR).
TB is Still Here – New CDC Data Show U.S. Cases Increased Again in 2022
Preliminary TB data released by CDC ahead of World TB Day show that the number of U.S. TB disease cases increased 5% in 2022 to 8,300 cases. CDC is calling on healthcare providers and communities disproportionately affected by TB to Think. Test. Treat TB.
CDC Acquires 465-Acre Site in Mace, West Virginia for Research Facility
CDC, along with the General Services Administration, today announced the acquisition of a site in Mace, West Virginia for a new facility that will focus on the mining industry and advance the agency’s research capabilities.
Increasing Threat of Spread of Antimicrobial-resistant Fungus in Healthcare Facilities
Candida auris (C. auris), an emerging fungus considered an urgent antimicrobial resistance (AR) threat, spread at an alarming rate in U.S. healthcare facilities in 2020-2021, according to data from the Centers for Disease Control and Prevention (CDC) published in the Annals of Internal Medicine.
U.S.-Led Global Effort Dramatically Increases Number of People Receiving Lifesaving HIV Treatment in Less than Two Decades
A new analysis from the Centers for Disease Control and Prevention reveals that the number of people receiving lifesaving HIV treatment through PEPFAR has increased 300 times in under 20 years, from 2004 to 2022.
CDC and ATSDR Staff Begin Next Steps in ACE Investigation in East Palestine, Ohio
The Centers for Disease Control and Prevention (CDC) and Agency for Toxic Substances and Disease Registry (ATSDR) are preparing for the next phase of the Assessment of Chemical Exposure (ACE) investigation to assess the health impacts of the February 3 train derailment that occurred in East Palestine, Ohio.
FDA and CDC Response to the Florida Surgeon General
FDA and CDC Response to the Florida Surgeon General regarding COVID-19 vaccine safety.
CDC Statement on President’s Fiscal Year 2024 Budget
Today, the Biden Administration released the President’s FY 2024 budget. The Centers for Disease Control and Prevention (CDC) budget request for FY 2024 includes $11.581 billion in discretionary budget authority, Prevention and Public Health Fund (PPHF), and PHS Evaluation Funds.

Health News

People with HIV have greater risk of ill health than others after hepatitis C cure

8 June 2023

People with HIV who were cured of hepatitis C remained at higher risk of a number of serious health outcomes including liver disease and heart disease than people without HIV in the five years after being cured, even after controlling for liver disease stage, the AIDS Clinical Trials Group reports in the journal Open Forum Infectious Diseases. [...]

UK cohort of elite controllers finds 32 people with undetectable viral loads who have never taken treatment

8 June 2023

Since 2017, UK researchers have identified a group of 32 ‘elite controllers’ – rare individuals who are living with HIV and are able to maintain undetectable viral load without taking antiretroviral therapy (ART) – and they expect to find more controllers over time. They have also been able to reassure another ten individuals who had ambiguous HIV test results that they don’t have HIV after all. [...]

Half of new HIV cases in African women could have been prevented had more programmes targeted men

8 June 2023

Had there been additional efforts to reach and maintain men in treatment services with HIV suppression at levels equal to that of their female counterparts between 2016 and 2018, half of the new infections in adolescent girls and women could have been averted, bringing gender equality in the HIV burden. An international team of researchers recently published these findings as a pre-print, which means they have not yet been reviewed by other scientists. [...]

Gay and bisexual men urged to get vaccinated against mpox as new cases reported

8 June 2023

As clusters of new mpox (formerly monkeypox) are reported in cities including London and Chicago, health officials are urging gay and bisexual men and transgender people to get vaccinated -- or to get their second dose if they’ve had only one. [...]

People with weakened immune systems still at risk of treatment failure, even with newer ART regimens

8 June 2023

Delays between acquiring HIV and initiating antiretroviral therapy (ART) often translates to people beginning treatment with weakened immune systems, a scenario that incurs a significantly higher risk that their therapy will fail to suppress the virus. Two new studies suggest that modern integrase inhibitor-based therapies currently recommended as part of first-line ART regimens do not mitigate that risk compared to older formulations. [...]

Real-world data confirm the efficacy of dolutegravir-based dual therapy

8 June 2023

Over six years’ worth of real-world data gathered from people with HIV switching to dolutegravir-based two-drug regimens confirm efficacy comparable to three-drug regimens, aligning with previous findings from clinical trials. Dr Conor Bowman and colleagues at the Royal Free Hospital published these findings in the journal AIDS. [...]

African countries are making the transition from donor-funded HIV programmes to government-led initiatives

8 June 2023

"We, as Africans, are the agenda and have the capacity to lead the HIV response. We need to create our own funding bill. Africans and its leaders have a role to play in conceptualising ideas and solutions," Yvette Raphael from the Advocates for the Prevention of HIV in Africa told the recent INTEREST conference in Maputo, Mozambique. Raphael urged governments and scientists to reduce their reliance on donor funding for HIV initiatives to achieve ownership and sustainable programmes. [...]

Social support for children living with HIV is a key determinant of treatment success, Senegal study shows

8 June 2023

A range of individual and collective factors contribute to HIV treatment success or failure among children and adolescents in Senegal, Dr Bernard Taverne at the University of Montpellier and colleagues report in Social Science & Medicine. Structural factors include the geographic accessibility of healthcare, universal health coverage and the availability of psychosocial support. Social factors include the child’s age, family relationships and social representations of HIV. [...]

Age and CD4 count have the greatest influence on life expectancy in the modern HIV treatment era

8 June 2023

A study published in this month’s Lancet HIV claims to have produced one of the most detailed analyses of life expectancy among people living with HIV in high-income countries in the modern treatment era. It found that for people on antiretroviral therapy (ART) and with high CD4 cell counts, life expectancy was only a few years lower than the general population, regardless of when they had started treatment. [GLOSSARY] [...]

Community support for caregivers helps children living with HIV achieve viral suppression

8 June 2023

Children living with HIV are less likely to achieve sustained viral load suppression if their caregivers are younger, if their caregivers are not virally suppressed or if the children are on a protease inhibitor-based regimen, the recent INTEREST 2023 conference in Maputo, Mozambique, heard. [...]

HEALTH A-Z

IMMUNOLOGY

Covid 19

CANCER

What is seborrheic keratosis, moles, warts?

HIV

Integrase inhibitors give greater chance of viral suppression in pregnant women

Improving Outcomes in HPV- and HIV-Related Cervical Cancer

References